Arlington Partners’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Arlington Partners's RGEN Position: Q2 2023 in Review
Arlington Partners sold out of Repligen (RGEN) in Q2 2023, closing a stake of 25 shares — an estimated $4.21K sold.
Arlington Partners first reported a position in RGEN in Q3 2021 and held it in 4 quarters. The position peaked at $161K in Q3 2021. 447 funds tracked by Wall St. Rank hold RGEN as of Q2 2023.
- Arlington Partners reported no remaining Repligen position as of Q2 2023 after selling out during the quarter.
- Arlington Partners sold 25 Repligen shares in Q2 2023, an estimated $4.21K.
- Arlington Partners first reported a position in Repligen in Q3 2021 and held it in 4 quarters.
- Arlington Partners's Repligen position peaked at $161K in Q3 2021.
- 447 funds tracked by Wall St. Rank held Repligen as of Q2 2023.
Based on Arlington Partners's 13F filing for Q2 2023, filed 26 Jul 2023.